homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

August 21, 2020

Chinook Therapeutics

Chinook Therapeutics announced $106 million in private placement financing from a number of new investors. As part of the financing, Chinook's existing investors — Versant Ventures, Apple Tree Partners and Samsara BioCapital — will purchase $25 million in Chinook common stock on the same terms as the new investors. The deal is expected to occur prior to the closing of the previously announced merger between Chinook and Aduro Biotech of Berkeley, California. Chinook is a clinical-stage biotechnology company developing medicines for kidney diseases. It has offices in Vancouver, B.C., and Seattle.




Email or user name:
Password:
 
Forgot password? Click here.